Holen Sie sich die Stockscreener-App
184.30
1.25%
-2.34
Handel nachbörslich:
184.35
0.05
+0.03%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt DHR?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$186.64
Offen:
$188
24-Stunden-Volumen:
3.31M
Relative Volume:
0.74
Marktkapitalisierung:
$130.44B
Einnahmen:
$24.78B
Nettoeinkommen (Verlust:
$3.68B
KGV:
35.62
EPS:
5.1743
Netto-Cashflow:
$5.29B
1W Leistung:
+0.89%
1M Leistung:
+5.54%
6M Leistung:
-18.54%
1J Leistung:
-4.09%
1-Tages-Spanne:
$183.79
$188.75
1-Wochen-Bereich:
$173.63
$188.75
52-Wochen-Spanne:
$160.93
$242.80
Danaher Corp Stock (DHR) Company Profile
Firmenname
Danaher Corp
Sektor
Branche
Telefon
(202) 828-0850
Adresse
2200 PENNSYLVANIA AVE. N.W., WASHINGTON, DC
Compare DHR vs TMO, IDXX, A, WAT
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DHR
Danaher Corp
|
184.30 | 132.10B | 24.78B | 3.68B | 5.29B | 5.1743 |
TMO
Thermo Fisher Scientific Inc
|
472.80 | 179.13B | 45.20B | 6.87B | 6.75B | 18.19 |
IDXX
Idexx Laboratories Inc
|
562.16 | 44.55B | 4.45B | 1.10B | 1.06B | 13.59 |
A
Agilent Technologies Inc
|
135.44 | 39.08B | 7.23B | 1.41B | 1.09B | 4.979 |
WAT
Waters Corp
|
365.36 | 36.96B | 3.77B | 449.25M | 240.68M | 7.8556 |
Danaher Corp Stock (DHR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-09 | Eingeleitet | Goldman | Buy |
| 2025-12-02 | Eingeleitet | Morgan Stanley | Overweight |
| 2025-10-08 | Herabstufung | Rothschild & Co Redburn | Buy → Neutral |
| 2025-07-11 | Hochstufung | Scotiabank | Sector Perform → Sector Outperform |
| 2025-04-10 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2025-03-21 | Hochstufung | Goldman | Neutral → Buy |
| 2025-03-14 | Hochstufung | Stifel | Hold → Buy |
| 2025-02-03 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2024-12-23 | Eingeleitet | Scotiabank | Sector Perform |
| 2024-12-19 | Eingeleitet | Guggenheim | Buy |
| 2024-12-13 | Hochstufung | BofA Securities | Neutral → Buy |
| 2024-10-31 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2024-10-01 | Eingeleitet | Stephens | Overweight |
| 2024-08-28 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-06-03 | Fortgesetzt | Jefferies | Buy |
| 2024-04-17 | Hochstufung | HSBC Securities | Hold → Buy |
| 2024-01-24 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2023-12-18 | Eingeleitet | HSBC Securities | Hold |
| 2023-12-13 | Fortgesetzt | Wolfe Research | Peer Perform |
| 2023-12-07 | Herabstufung | Goldman | Buy → Neutral |
| 2023-07-19 | Eingeleitet | Raymond James | Outperform |
| 2023-05-01 | Eingeleitet | SVB Securities | Outperform |
| 2023-04-26 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-04-18 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-01-05 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2022-12-14 | Eingeleitet | Deutsche Bank | Buy |
| 2022-10-24 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2022-08-25 | Eingeleitet | Credit Suisse | Outperform |
| 2022-08-17 | Fortgesetzt | Bernstein | Outperform |
| 2022-07-20 | Eingeleitet | UBS | Buy |
| 2022-06-01 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-04-25 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-01-11 | Eingeleitet | Bernstein | Outperform |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-09-10 | Bestätigt | BofA Securities | Buy |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-07-23 | Bestätigt | Goldman | Buy |
| 2021-07-16 | Eingeleitet | The Benchmark Company | Buy |
| 2021-04-07 | Fortgesetzt | Robert W. Baird | Outperform |
| 2021-03-03 | Fortgesetzt | Barclays | Overweight |
| 2020-12-02 | Eingeleitet | Goldman | Buy |
| 2020-11-25 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2020-06-16 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2020-04-02 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2020-03-26 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-02-03 | Bestätigt | Needham | Buy |
| 2020-01-08 | Eingeleitet | Wells Fargo | Overweight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2019-11-15 | Fortgesetzt | Stifel | Hold |
| 2019-10-28 | Bestätigt | Needham | Buy |
| 2019-10-14 | Fortgesetzt | Credit Suisse | Outperform |
| 2019-07-19 | Bestätigt | Needham | Buy |
| 2019-06-11 | Eingeleitet | Piper Jaffray | Neutral |
| 2019-05-30 | Eingeleitet | Wolfe Research | Outperform |
| 2019-04-17 | Bestätigt | Needham | Buy |
| 2019-02-28 | Bestätigt | Needham | Buy |
| 2019-02-25 | Hochstufung | Janney | Neutral → Buy |
| 2019-01-03 | Eingeleitet | Needham | Buy |
| 2018-04-20 | Bestätigt | Stifel | Buy |
Alle ansehen
Danaher Corp Aktie (DHR) Neueste Nachrichten
Danaher Insiders Sold US$235m Of Shares Suggesting Hesitancy - Yahoo Finance
Dominion Energy Inc stock (US2358511028): shares ease while investors weigh earnings and sector outl - AD HOC NEWS
Chemiluminescence Immunoassay Market Expected to Reach USD 16.39 Billion by 2031 | MarketsandMarkets™ - GlobeNewswire Inc.
Is It Too Late to Buy Danaher Corp (DHR) After 4.8% Rally? GF Va - GuruFocus
CIBC Atlas Income Opportunities Fund's Danaher Corp(DHR) Holding History - GuruFocus
Danaher Corp. stock outperforms competitors on strong trading day - MarketWatch
Danaher jumps as investors focus on fresh financing steps and Masimo deal progress - Quiver Quantitative
IDBS i3 2026 forum in Boston showcases real-world customer outcomes in data-driven BioPharma - Yahoo Finance
Masimo Stock Is Stuck Just Below Danaher’s $180 Bid. The Gap Is the Story - Bez Kabli
Jim Cramer on Danaher: “At These Prices, It’s Clearly Overvalued” - Insider Monkey
Is Danaher stock underperforming the S&P 500? - MSN
Danaher (NYSE: DHR) issues long-dated CHF senior notes for general purposes - Stock Titan
Leica Biosystems Announces Expansion of Collaboration to Scale Precision Medicine and Develop AI-Powered Diagnostics - PR Newswire
Danaher Corp. stock outperforms competitors despite losses on the day - MarketWatch
DHR Assumed by Wolfe Research -- Rating Set to Peer Perform - GuruFocus
Here are Tuesday’s top Wall Street analyst research calls: CoreWeave, Danaher, Hewlett Packard Enterprise, Intuit, Knight-Swift, Meta Platforms, Starwood Property Trust, Tripadvisor, and more - MSN
What Danaher (DHR)'s New AI-Enabled SCIEX Mass Spec Platform Means For Shareholders - simplywall.st
Is It Time To Reassess Danaher (DHR) After Its Recent Share Price Weakness? - Yahoo Finance
Danaher Corp. stock (US2358511028): Wolfe Research starts coverage as shares trade lower - AD HOC NEWS
Here Are Tuesday’s Top Wall Street Analyst Research Calls: CoreWeave, Danaher, Hewlett Packard Enterprise, Intuit, Knight-Swift, Meta Platforms, Starwood Property Trust, Tripadvisor, and More - Yahoo Finance
Danaher Corp. May Be the Smartest Bet in Biotech Right Now - AOL.com
DoorDash Inc stock (US2358511028): shares advance as earnings momentum and US food delivery demand s - AD HOC NEWS
Wolfe Research initiates Danaher stock coverage with Peerperform rating By Investing.com - Investing.com South Africa
Wolfe Research initiates Danaher stock coverage with Peerperform rating - Investing.com
Danaher Corp. stock (US2358511028): shares ease while investors digest product updates and analyst b - AD HOC NEWS
Danaher Corp. stock underperforms Monday when compared to competitors - MarketWatch
Phenomenex Launches Endrix Long Life Columns, Redefining Column Durability and Method Reliability - digitalmore.co
SCIEX launches novus V55 mass spectrometer system By Investing.com - Investing.com South Africa
SCIEX introduces software and hardware updates for ZenoTOF line By Investing.com - Investing.com Australia
SCIEX launches novus V55 mass spectrometer system - Investing.com UK
SCIEX introduces software and hardware updates for ZenoTOF line - Investing.com UK
Dominion Energy Inc stock (US2358511028): shares ease after recent ex-dividend date - AD HOC NEWS
SCIEX Launches the novus V55 System With SCIEX OS 5.0 Software and AI Enablement Tools - 巴士的報
SCIEX unveils 1-sample-per-second mass spec to speed early discovery - Stock Titan
Integrated DNA Technologies (DHR) Partners with Illumina for Enh - GuruFocus
Integrated DNA Technologies Announces End-to-End Oncology Research Workflows Optimized on Illumina Software for Faster Insights - StreetInsider
Phenomenex Launches Endrix Long Life Columns, Redefining Column Durability and Method Reliability | Newswise - Newswise
Danaher Corp. Hits Day High with Strong 4.33% Intraday Surge - Markets Mojo
Leica Biosystems and CellCarta Expand Collaborative Companion Diagnostic Development Model to Accelerate Commercialization Globally - PR Newswire
Is Danaher Stock Underperforming the S&P 500? - Yahoo Finance
Danaher Corp. stock (US2358511028): valuation metrics in focus after Q1 guidance raise - AD HOC NEWS
A Look at Danaher Corp (DHR) After 4.3% Gain -- GF Value $236.05 vs Price $180.63 - GuruFocus
Danaher Corp. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Danaher Corp Stock (DHR) Moved Up by 3.30% on May 28: A Full Analysis - TradingKey
Rainer Blair: Innovative Leader, Danaher Business System Champion, and President and Chief Executive Officer of Danaher Corporation - BBN Times
Danaher (DHR) Receives Buy Rating from Citi with $230 Price Targ - GuruFocus
DHR Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Danaher (DHR) Downgraded by Citigroup -- Price Target Lowered to $95 - GuruFocus
RBC Capital Resumes Coverage of Danaher Corporation (DHR) - Insider Monkey
Danaher Corp. stock (US2358511028): dividend timeline and institutional interest in focus - AD HOC NEWS
Cytiva introduces next-gen Biacore 8 series SPR systems for drug discovery - BioSpectrum Asia
Finanzdaten der Danaher Corp-Aktie (DHR)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.91%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):